Oncology & Cancer

Cancer screening and detection remain below prepandemic levels

At the end of 2021, population-based screening and diagnosis remained below prepandemic levels for breast, cervical, and colorectal cancers, according to a research letter published online Nov. 17 in JAMA Oncology.

Oncology & Cancer

Benefit of risk-based breast cancer screening is still unclear

The Austrian Institute for Health Technology Assessment (AIHTA) has analyzed whether risk-based breast cancer screening has advantages over the conventional age-based screening program. The central result: the current prediction ...

page 8 from 40